Accelerating Pharmaceutical Innovation
Through Data-Driven Multi-Omics Discovery
We partner with top-tier global pharmaceutical organizations and emerging biotech leaders to de-risk R&D pipelines, advance companion diagnostic programs, and compress development timelines from target identification through regulatory submission.
Transforming Biological Complexity into Commercial Pipeline Value
Calivanta BioPharma builds AI-powered molecular design platforms that drive in-silico drug discovery, protein engineering, and precision medicine — across our own pipeline and in partnership with pharmaceutical companies worldwide.
AI-Driven Drug Discovery, Protein Design, and Bioinformatics Platforms
Our proprietary platforms combine molecular simulation, computational protein design, genomics, and bioinformatics to speed up therapeutic discovery — from in-silico target validation to precision medicine biomarker development.
Target Discovery & Validation
CaliOmics combines multi-omics analysis with molecular dynamics simulation to identify and validate novel therapeutic targets. By integrating CRISPR screening data, GWAS meta-analyses, and proprietary pathway models, we cut target attrition and speed up hit-to-lead timelines.
Biomarker Discovery & Companion Diagnostics
TherAlign uses machine learning to identify predictive biomarkers across solid tumors and hematological malignancies. Several biomarker panels are currently in co-development with pharma partners, supporting precision medicine and companion diagnostic programs.
Precision Medicine & Immuno-Oncology Analytics
ImmunoScope provides end-to-end immune profiling for IO drug development, analyzing T-cell receptor repertoires, tumor microenvironment transcriptomics, and circulating immune cell dynamics. Now in pilot programs with three major pharma partners developing next-gen checkpoint inhibitors and CAR-T therapies.
Mechanism of Action & Regulatory Strategy
PathwayPredict applies systems pharmacology and network analysis to deconvolute drug mechanisms of action and predict off-target effects. ClinicalConnect pulls real-world evidence from EHR and claims data to optimize trial design and support FDA and EMA regulatory filings.
Enterprise-Grade Infrastructure and Proprietary Bioinformatics Pipelines
We run dedicated high-performance compute infrastructure built for molecular simulation and multi-omics workloads. End-to-end encryption, SOC 2 Type II, GDPR, and HIPAA compliance. Elastic scaling from pilot studies to population-level analyses.
CaliOmics Analytics Engine
Proprietary computational framework integrating 5 omics layers with a multi-layer computational approach, trained on curated public and partner-proprietary datasets
Enterprise Security & Compliance
SOC 2 Type II certified, HIPAA-aligned data handling, GDPR-compliant processing, and strict IP firewalls with partner-specific access controls
Scalable Cloud-Native Architecture
Elastic infrastructure supporting projects from single-cell RNA-seq pilot studies to multi-cohort, population-scale WGS and metabolomics analyses
Tailored Solutions for Global Pharmaceutical and Biotech Partners
We advance our proprietary pipeline while partnering with global pharma organizations — from platform co-development with leading companies to strategic collaborations with emerging biotech innovators using our discovery engines.
Top-Tier Global Pharmaceutical Companies
Multi-year platform co-development, precision medicine joint ventures, regulatory submission support (FDA/EMA), and enterprise-scale RWE analytics for portfolio prioritization
Emerging Biotechnology Firms
On-demand access to enterprise-grade discovery platforms, flexible milestone-based engagements, and technical due diligence for financing rounds
CROs & Academic Medical Centers
White-label bioinformatics pipeline licensing, clinical trial biomarker monitoring, translational research frameworks, and grant-supported co-development of novel analytical methods
Worldwide Infrastructure Supporting Multi-Continent Partnerships
Headquartered in Switzerland with operations in Europe and North America. Our regional teams provide local regulatory expertise, data sovereignty compliance, and dedicated partnership management across US and European markets.
Switzerland
Global Headquarters & European R&D Hub
Europe
European Operations Center & EMA Regulatory Affairs
North America
North American Business Development & FDA Strategy Office
Our Basel headquarters coordinates global R&D and partner engagement. Our European and North American offices handle local regulatory strategy, data sovereignty, and account management across all major pharma markets.